[Lymphogenous encephalopathy: a new clinical picture and its management].
D000328:Adult; D000818:Animals; D001927:Brain Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D002555:Cerebrospinal Fluid / Q000032:analysis; D002560:Cerebrovascular Circulation; D002648:Child; D002986:Clinical Trials as Topic; D004569:Electroencephalography; D004660:Encephalitis / Q000150:complications; D004827:Epilepsy / Q000175:diagnosis; D005094:Exophthalmos; D005132:Eye Manifestations; D005260:Female; D006801:Humans; D006849:Hydrocephalus; D007267:Injections; D007427:Intracranial Pressure; D008199:Lymphadenitis; D008205:Lymphangitis; D008206:Lymphatic Diseases / Q000150:complications; D008208:Lymphatic System / Q000033:anatomy & histology; D008297:Male; D008556:Melkersson-Rosenthal Syndrome / Q000175:diagnosis; D009333:Neck / Q000033:anatomy & histology; D009461:Neurologic Manifestations; D010038:Otorhinolaryngologic Diseases / Q000150:complications; D010205:Pantothenic Acid / Q000627:therapeutic use; D010433:Pentylenetetrazole / Q000494:pharmacology; D010919:Placebos; D011559:Pseudotumor Cerebri / Q000175:diagnosis; D011581:Psychological Tests; D011736:Pyridoxine / Q000627:therapeutic use; D051381:Rats; D012877:Skin Manifestations
D010919:Placebos; D010205:Pantothenic Acid; D011736:Pyridoxine; D010433:Pentylenetetrazole
Lymphogene Enzephalopathie. Ein neues Krankheitsbild und seine Behandlung.